2021.3
Jiaxing Xinwen Biotechnology Co., Ltd. has signed a project investment agreement with the Jiashan County Guigu Park Management Committee to establish a wholly-owned subsidiary in Jiashan - X···
Language
Innovative transdermal drug delivery technology as the core biopharmaceutical product technology platform
Jiaxing Xinwen Biotechnology Co., Ltd. has signed a project investment agreement with the Jiashan County Guigu Park Management Committee to establish a wholly-owned subsidiary in Jiashan - X···
Jiaxing Xinwen Biotechnology Co., Ltd. Completed the First Round of Financing
The first domestic transdermal sufentanil patch developed for Yichang Humanwell obtained clinical approval from the State Drug Administration
The Huzhou Transdermal Drug Delivery Research Laboratory has been relocated to Jiaxing, and the Jiaxing Innovative Formulation Biopharmaceutical Product Experimental Center has officially op···
Awarded the title of "Zhejiang Province Science and Technology oriented Small and Medium Enterprises"